Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Power is a biotechnology company based in Chengdu, China, that specializes in AI-driven drug discovery through advanced molecular dynamics (MD) simulations. The company utilizes physics-based modeling and high-performance computing to predict molecular interactions and optimize drug candidates with high precision. Their proprietary platform aims to overcome the limitations of traditional screening methods by providing deeper insights into protein-ligand binding kinetics and thermodynamics. Molecular Power primarily focuses on the development of novel small molecule therapeutics for oncology and other challenging disease areas. By integrating structural biology with cutting-edge algorithms, the company seeks to significantly accelerate the drug development timeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Molecular Power Biotechnology.